Dr. Zerrin Kutlu is a dedicated biochemist at Ataturk University whose work bridges academic research and translational biomedical applications, with expertise shaped through comprehensive education in biochemistry and continuous engagement in laboratory-based investigations. She has developed strong professional experience in studying oxidative and endoplasmic reticulum stress, inflammation, metabolic dysfunction, and organ injury, contributing extensively to scientific literature and interdisciplinary collaborations. Her research interests span cardiometabolic injury, diabetes complications, sepsis physiology, osteoporosis biology, redox mechanisms, ferroptosis, nanoformulations, and boron-based dermocosmetic innovations. She is skilled in experimental disease modeling, molecular assays, biomarker analysis, antioxidant therapeutics, nanotechnology-driven drug delivery, and evaluation of natural and synthetic cytoprotective agents. Her contributions include leading and participating in funded scientific projects, developing innovative therapeutic concepts, and offering consultancy for university–industry partnerships focused on bioactive compounds and product development. She has earned recognition through editorial roles in respected journals, active membership in scientific networks, and authorship of book chapters and impactful publications. Dr. Kutlu continues to advance her field with a commitment to rigorous research, innovation, and scientific integrity, and her growing portfolio reflects a career devoted to improving biomedical understanding and fostering solutions that support human health and translational progress.